rivaroxaban-based strategy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rivaroxaban-based strategy, covering 2020-01-18 to 2020-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) [Phase 3]